These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33198953)
1. Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review. Supe S; Upadhya A; Singh K Exp Eye Res; 2021 Jan; 202():108329. PubMed ID: 33198953 [TBL] [Abstract][Full Text] [Related]
2. Development of gene therapy for treatment of age-related macular degeneration. Askou AL Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037 [TBL] [Abstract][Full Text] [Related]
4. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy. Guzman-Aranguez A; Loma P; Pintor J Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539 [TBL] [Abstract][Full Text] [Related]
5. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes. Golkar N; Samani SM; Tamaddon AM Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973 [TBL] [Abstract][Full Text] [Related]
6. Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update. Lin FL; Wang PY; Chuang YF; Wang JH; Wong VHY; Bui BV; Liu GS Mol Ther; 2020 Oct; 28(10):2120-2138. PubMed ID: 32649860 [TBL] [Abstract][Full Text] [Related]
7. Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal neovascularization in mice model. Kong YC; Sun B; Zhao KX; Han M; Wang YC Chin Med J (Engl); 2013; 126(8):1440-4. PubMed ID: 23595374 [TBL] [Abstract][Full Text] [Related]
8. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. Kim SH; Jeong JH; Lee SH; Kim SW; Park TG J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481 [TBL] [Abstract][Full Text] [Related]
10. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365 [TBL] [Abstract][Full Text] [Related]
11. Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. Amadio M; Pascale A; Cupri S; Pignatello R; Osera C; D Agata V; D Amico AG; Leggio GM; Ruozi B; Govoni S; Drago F; Bucolo C Pharmacol Res; 2016 Sep; 111():713-720. PubMed ID: 27475885 [TBL] [Abstract][Full Text] [Related]
12. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393 [TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of retinal and choroidal vascular diseases. Campochiaro PA Prog Retin Eye Res; 2015 Nov; 49():67-81. PubMed ID: 26113211 [TBL] [Abstract][Full Text] [Related]
14. Liposome-polyethylenimine complexes for the effective delivery of HuR siRNA in the treatment of diabetic retinopathy. Supe S; Upadhya A; Tripathi S; Dighe V; Singh K Drug Deliv Transl Res; 2023 Jun; 13(6):1675-1698. PubMed ID: 36630075 [TBL] [Abstract][Full Text] [Related]
15. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Kleinman ME; Yamada K; Takeda A; Chandrasekaran V; Nozaki M; Baffi JZ; Albuquerque RJ; Yamasaki S; Itaya M; Pan Y; Appukuttan B; Gibbs D; Yang Z; Karikó K; Ambati BK; Wilgus TA; DiPietro LA; Sakurai E; Zhang K; Smith JR; Taylor EW; Ambati J Nature; 2008 Apr; 452(7187):591-7. PubMed ID: 18368052 [TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
17. Efficient siRNA Delivery Using PEG-conjugated PAMAM Dendrimers Targeting Vascular Endothelial Growth Factor in a CoCl2-induced Neovascularization Model in Retinal Endothelial Cells. Xu L; Shen W; Wang B; Wang X; Liu G; Tao Y; Qi R Curr Drug Deliv; 2016; 13(4):590-9. PubMed ID: 26279119 [TBL] [Abstract][Full Text] [Related]
18. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy. Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764 [TBL] [Abstract][Full Text] [Related]
19. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. Kim SH; Jeong JH; Lee SH; Kim SW; Park TG J Control Release; 2008 Jul; 129(2):107-16. PubMed ID: 18486981 [TBL] [Abstract][Full Text] [Related]
20. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization]. Fan SJ; He SZ Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]